The Estee Lauder Companies announced that the company and several of its brands presented a range of novel preclinical and clinical findings at the 25th World Congress of Dermatology, held this week in Singapore. Poster details highlighting key data include: The benefits of regular use of moisturizer to skin aging prevention: a six-month evaluator blinded, randomized, and controlled clinical study, with results revealing that regular application of a potent moisturizer can not only treat skin dryness, but also improve the dry skin stratum corneum cohesion to reduce the appearance of facial aging; The effect of a multi-ingredient facial cream on skin structure, function, and appearance, with findings suggesting the facial cream provides an effective treatment for improving barrier integrity and strength as well as signs of aging parameters and skin appearance with regular daily use.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EL:
- Estee Lauder price target lowered to $205 from $235 at BofA
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Estee Lauder to present preclinical results on anti-aging products at WCD
- Why Estée Lauder Stock (NYSE:EL) Has an Ace Up Its Sleeve
- Early notable gainers among liquid option names on June 14th